NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
about
The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic ConformationCoupling of receptor conformation and ligand orientation determine graded activityStructural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutesStructural Mechanisms of Allostery and Autoinhibition in JNK Family KinasesDevelopment of Selective Estrogen Receptor Modulator (SERM)-Like Activity Through an Indirect Mechanism of Estrogen Receptor Antagonism: Defining the Binding Mode of 7-Oxabicyclo[2.2.1]hept-5-ene Scaffold Core LigandsX-ray Structures of Progesterone Receptor Ligand Binding Domain in Its Agonist State Reveal Differing Mechanisms for Mixed Profiles of 11 -Substituted SteroidsResveratrol modulates the inflammatory response via an estrogen receptor-signal integration networkUnprecedented conformational flexibility revealed in the ligand-binding domains of the Bovicola ovis ecdysone receptor (EcR) and ultraspiracle (USP) subunitsESR1 ligand-binding domain mutations in hormone-resistant breast cancer.Antiestrogens: structure-activity relationships and use in breast cancer treatmentPredictive features of ligand-specific signaling through the estrogen receptorMonitoring a coordinated exchange process in a four-component biological interaction system: development of a time-resolved terbium-based one-donor/three-acceptor multicolor FRET systemDiosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytesThe atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferationEffects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands.The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.Structural and functional profiling of environmental ligands for estrogen receptors.The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligandsEstrogen receptor mutations and their role in breast cancer progressionIdentification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.Structural mechanism for signal transduction in RXR nuclear receptor heterodimers.Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics.Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discoverySystematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based ApproachDual suppression of estrogenic and inflammatory activities for targeting of endometriosisEstrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation.ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction.Nonclassical SNAPFL analogue as a Cy5 resonance energy transfer partnerFull antagonism of the estrogen receptor without a prototypical ligand side chain.Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor.Exploring the Structural Compliancy versus Specificity of the Estrogen Receptor Using Isomeric Three-Dimensional Ligands.The nuclear receptor signalling scaffold: insights from full-length structures.Oxabicycloheptene Sulfonate Protects Against β-Amyloid-induced Toxicity by Activation of PI3K/Akt and ERK Signaling Pathways Via GPER1 in C6 Cells.Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer.
P2860
Q27654859-5582F731-D6D6-40E3-AC51-EC5693AA6C55Q27664921-7D860DE6-6324-4B8A-B212-E90C0C9D1C2BQ27671720-6CB1F772-4BDA-47ED-95C4-B9EF671987B4Q27675044-4EB79935-D1F9-4251-8076-29E4AC97377BQ27678627-1B4F3DDF-8992-446F-BD6E-41E58AAB19A0Q27678748-B5498E30-5784-4ECB-A71A-57E0A90B3FA2Q27683572-3A29B07A-6A6E-40E1-9134-F75434823630Q27694508-4E4D5DA1-A2CF-41C9-A4B7-13A13CE62DD2Q27852637-6926C22E-B805-47D0-82FC-24D60E6F970DQ28077245-D7453751-8AC9-4EFB-B2BC-034C2E3E0B62Q28603633-5B0EA880-A798-4938-8F8B-3D790E73964BQ33815496-119D0434-FA91-4D4D-A644-473CBF0D6700Q33823673-04904F2F-0F34-410A-9D43-357A4897A509Q33929484-FAAAC6E3-BFB8-4AE1-BD3D-D163CE8D0841Q34077212-013DDA62-C642-4C0F-BAF0-D4273189BB28Q34205758-246D918D-8EE2-408B-8993-8401FCBBE7DCQ34347992-6066664D-A5A0-4181-8C9B-B798221057EDQ34534031-A29A31B4-771C-40F4-86C8-AB38D6B8731CQ34607003-CFA8F3E6-2A12-4AB2-996C-A99AC644B540Q34632938-D5394CFF-BF74-4457-9D32-9C47E5F43D90Q35148605-C10DB687-57B9-404F-8FFB-98C07D58C021Q35599448-0A2355A1-F5B7-4170-A7C0-799C0AF61218Q35815534-B48A2F73-4FBC-4145-89D8-B68D0658E790Q35990304-B8A2D129-A7C0-43FB-9A79-F7827C0E93C6Q36185635-6096189C-DB35-4720-8DB4-3C7B236671F1Q36405734-B3FE7ECA-2354-4E2D-B97A-EFEFDC7771FEQ36497819-E1ADAC1A-1B63-4D4F-AFBD-BCE1B332687FQ36539506-0FB83034-E828-466A-8EDC-BF7A9C99B872Q36683035-8098CE3A-75EE-4C7C-8D4B-17CF6F729F9BQ36768079-D727ADD6-7155-4DAF-9109-3848205C3522Q37013898-4A3CE93B-5F95-47FF-855C-443F92BC8D04Q37135807-0A05FB97-7A46-4379-9935-9B4619977A4FQ37453690-6B380AA6-5D29-429A-BE92-FCB8AF8313E5Q37510434-F160B2F1-EB0B-4D71-935D-FFF690C10BABQ37727682-F514E616-B776-48BF-B9E0-49D314B9F21BQ38434128-E9C89904-E5EA-4EF3-B0E0-F4717F58065FQ38460501-60B10344-86A7-4E03-8042-7DD78D4D0D1EQ38709034-FB443352-1590-4BF8-8EB1-AE9F8C1E082BQ39093601-2FF28D25-1A3F-4802-A82A-72F5BF36B998Q39218132-A97D076A-BB3B-43F8-BF46-B2F27F8D5C50
P2860
NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@ast
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@en
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@nl
type
label
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@ast
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@en
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@nl
prefLabel
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@ast
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@en
NFκB selectivity of estrogen r ...... tive crystallographic analyses
@nl
P2093
P2860
P50
P3181
P356
P1476
NFkappaB selectivity of estrog ...... tive crystallographic analyses
@en
P2093
Andrzej Joachmiak
Geoffrey L Greene
Jason Nowak
John A Katzenellenbogen
John B Bruning
Johnnie B Hahm
Kendall W Nettles
Kristen Kulp
Richard B Hochberg
Younchang Kim
P2860
P2888
P304
P3181
P356
10.1038/NCHEMBIO.76
P577
2008-03-16T00:00:00Z
P5875
P6179
1025380413